Trial design
For this trial, we will perform a single-center prospective randomized two-arm parallel-group superiority trial to evaluate the effectiveness of two linkage-to-care strategies for patients newly identified with untreated HCV in the ED from the DETECT Hep C Screening Trial or through an active surveillance process of previously diagnosed patients (Fig. Study schematic for the The DETECT Hep C Trials, including the emergency department (ED) screening trial (